ECSP993128A - Denaturants for sympathomimetic amine salts - Google Patents
Denaturants for sympathomimetic amine saltsInfo
- Publication number
- ECSP993128A ECSP993128A ECSP993128A ECSP993128A EC SP993128 A ECSP993128 A EC SP993128A EC SP993128 A ECSP993128 A EC SP993128A EC SP993128 A ECSP993128 A EC SP993128A
- Authority
- EC
- Ecuador
- Prior art keywords
- sympathomimetic amine
- compositions
- amine
- sympathomimetic
- combination
- Prior art date
Links
- 239000000150 Sympathomimetic Substances 0.000 title abstract 6
- 230000001975 sympathomimetic effect Effects 0.000 title abstract 6
- -1 amine salts Chemical class 0.000 title abstract 2
- 239000003398 denaturant Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 7
- 150000001412 amines Chemical class 0.000 abstract 5
- 239000003112 inhibitor Substances 0.000 abstract 4
- 238000006243 chemical reaction Methods 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000000926 separation method Methods 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 abstract 1
- 229960001252 methamphetamine Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 229960003447 pseudoephedrine hydrochloride Drugs 0.000 abstract 1
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
La presente invención hace no practicable el uso de composiciones de amina simpaticomimética en la producción ilícita de drogas. Mas especificamente, se inhibe la preparación de la metanfetamina a partir de las formulaciones de clorhidrato de pseudoefedrina reveladas. La presente invención define composiciones farmacéuticas que comprenden una sal de amina simpaticomimétrica y al menos un inhibidor de combinación, el inhibidor de combinación que actua tanto para interferir en el aislamiento de la amina simpaticomimética de la composición como para interferir en la conversión de la amina simpaticomimética en otro compuesto farmacológicamente activo. Las composiciones contempladas también pueden incluir inhibidores de reacción y de separación en cualquier mezcla para asegurar la máxima protección contra el uso de composiciones que contienen amina simpaticomimética para la fabricación ilegal de drogas. La presencia de los inhibidores de combinación, reacción y separación no altera demanera significativa la liberación de la amina simpaticomimética de la composición.The present invention renders the use of sympathomimetic amine compositions in the illicit production of drugs impractical. More specifically, the preparation of methamphetamine from the disclosed pseudoephedrine hydrochloride formulations is inhibited. The present invention defines pharmaceutical compositions comprising a sympathomimetric amine salt and at least one combination inhibitor, the combination inhibitor which acts both to interfere with the isolation of the sympathomimetic amine from the composition and to interfere with the conversion of the sympathomimetic amine. in another pharmacologically active compound. The contemplated compositions may also include reaction and separation inhibitors in any mixture to ensure maximum protection against the use of sympathomimetic amine-containing compositions for the illegal manufacture of drugs. The presence of the combination, reaction and separation inhibitors does not significantly alter the release of the sympathomimetic amine from the composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993128 ECSP993128A (en) | 1999-09-09 | 1999-09-09 | Denaturants for sympathomimetic amine salts |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993128 ECSP993128A (en) | 1999-09-09 | 1999-09-09 | Denaturants for sympathomimetic amine salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993128A true ECSP993128A (en) | 1999-11-29 |
Family
ID=42044116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993128 ECSP993128A (en) | 1999-09-09 | 1999-09-09 | Denaturants for sympathomimetic amine salts |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993128A (en) |
-
1999
- 1999-09-09 EC ECSP993128 patent/ECSP993128A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV1999000148A (en) | Denaturants for sympathomimetic amine salts | |
| ECSP077999A (en) | FORMULATIONS OF A MODIFIED LIBERATION BUPROPION SALT | |
| UY30438A1 (en) | N-SUBSTITUTED DERIVATIVES OF 5-HALO-4- [2-RENT-1-SUBSTITUTES-1H-IMIDAZOL-5-IL] PIRIMIDIN-2-AMINA, COMPOSITIONS-PROCESSES FOR PREPARATION AND USES | |
| CR8859A (en) | PIRIDINE DERIVATIVES | |
| BR0207872A (en) | Active agent release compound, composition, unit dosage form and method of administration | |
| BR0112311A (en) | Active agent release compounds and compositions, unit dosage form, method for preparing said compositions and their use | |
| CR9954A (en) | PIRAZINE DERIVATIVES | |
| HN2001000224A (en) | IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI - INFLAMMATORY AND ANALGESIC AGENTS. | |
| ES2088312T3 (en) | CONTROLLED RELEASE FORMULATION CONTAINING TRAMADOL. | |
| BR0214199A (en) | Phenoxy amine compositions to release active agents, dosage unit form and method of administration | |
| PA8507601A1 (en) | NEW BENZOIMIDAZOL USEFUL DERIVATIVES AS ANTIPROLIFERATIVE AGENTS | |
| ECSP066990A (en) | FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE PRINCIPLE CONTAINING VARDENAFILO | |
| BR0306870A (en) | Oral pharmaceutical composition and method for preparing the same | |
| ECSP088587A (en) | PIPERIDINE COMPOUNDS 3,5-REPLACED AS RENINE INHIBITORS | |
| CO5580767A2 (en) | INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINES AND PROCEDURES FOR USE | |
| BRPI0415053A (en) | p-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same | |
| UA90518C2 (en) | Pharmaceutical composition in the form of a tablet suitable for dissolution in the buccal cavity, comprising a narcotic active ingredient and amine | |
| UY25234A1 (en) | VENLAFAXINE PROLONGED RELEASE FORMULATION | |
| CU23264B7 (en) | PREPARED DELAYED RELEASE OF ANTIBIOTICS OF QUINOLONA AND PROCEDURE FOR PREPARATION | |
| UY27979A1 (en) | INDOLES REPLACED IN POSITION 2,4 | |
| PE20150773A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF PHENYLEPHRINE | |
| AR048336A1 (en) | HYDROCLORIDE OF (4- (5-AMINOMETIL-2-FLUORO-PHENYL) -PIPERIDIN-1-IL) - (4-BROMO-3-METHYL-5-PROPOXI-TIOFEN-2-IL) -METANONE AS AN INHIBITOR OF THE MASTOCYT TRIPTASE | |
| UY27980A1 (en) | INDOLES 2,7-REPLACED | |
| AR029347A1 (en) | ADENINE COMPOUND, ISOGNANINE COMPOUND AND 2,6-DITIOXANTINE AS A PRECURSOR OF THE SAME, USE OF SUCH COMPOUNDS TO PREPARE A PHARMACEUTICAL COMPOSITION AND SUCH PHARMACEUTICAL COMPOSITION | |
| HN2000000045A (en) | NEW PHARMACEUTICAL COMBINATIONS FOR INHIBITORS OF THE US. |